Lim K, Kim S, Kim H, Kang J, Park J, Won J
BMC Neurol. 2022; 22(1):288.
PMID: 35922754
PMC: 9347126.
DOI: 10.1186/s12883-022-02818-8.
Di Genova L, Perruccio K, Celani M, Mastrodicasa E, Cantisani T, Esposito S
Front Pharmacol. 2019; 10:963.
PMID: 31551775
PMC: 6734028.
DOI: 10.3389/fphar.2019.00963.
Triarico S, Maurizi P, Mastrangelo S, Attina G, Capozza M, Ruggiero A
Cancers (Basel). 2019; 11(6).
PMID: 31200562
PMC: 6627959.
DOI: 10.3390/cancers11060824.
Santos J, Pyter L
Front Immunol. 2018; 9:1195.
PMID: 29930550
PMC: 6001368.
DOI: 10.3389/fimmu.2018.01195.
Coker S, Pastel D, Davis M, Bengtson E, Fadul C, Lewis L
SAGE Open Med Case Rep. 2017; 5:2050313X17706875.
PMID: 28515935
PMC: 5423709.
DOI: 10.1177/2050313X17706875.
Neurological complications of coeliac disease.
Tengah D, Wills A, Holmes G
Postgrad Med J. 2002; 78(921):393-8.
PMID: 12151653
PMC: 1742420.
DOI: 10.1136/pmj.78.921.393.
Intravenous methotrexate as initial treatment for primary central nervous system lymphoma: response to therapy and quality of life of patients.
Guha-Thakurta N, Damek D, Pollack C, Hochberg F
J Neurooncol. 1999; 43(3):259-68.
PMID: 10563432
DOI: 10.1023/a:1006210703827.
Reversal of CNS-prophylaxis-related leukoencephalopathy after CSF shunting: case histories of identical twins.
Tekkok I, Carter D, Robinson M, Brinker R
Childs Nerv Syst. 1996; 12(6):309-14.
PMID: 8816294
DOI: 10.1007/BF00301018.
Atypical MRI findings in treatment-related leukoencephalopathy: case report.
Ohmoto Y, Kajiwara K, Kato S, NISIZAKI T, Ito H, Tamura S
Neuroradiology. 1996; 38(2):128-33.
PMID: 8692421
DOI: 10.1007/BF00604796.
Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment.
Vainionpaa L
Eur J Pediatr. 1993; 152(2):115-9.
PMID: 8444217
DOI: 10.1007/BF02072486.
Folates and psychiatric disorders. Clinical potential.
Crellin R, Bottiglieri T, Reynolds E
Drugs. 1993; 45(5):623-36.
PMID: 7686459
DOI: 10.2165/00003495-199345050-00001.
CT studies before and after CNS treatment for acute lymphoblastic leukemia and malignant non-hodgkin's lymphoma in childhood.
Kretzschmar K, Gutjahr P, Kutzner J
Neuroradiology. 1980; 20(4):173-80.
PMID: 6970344
DOI: 10.1007/BF00336678.
Calcified cerebral necrosis following ALL therapy.
Muller K, Menne R, BACHMANN K, Grobe H
J Cancer Res Clin Oncol. 1981; 102(1):81-91.
PMID: 6949906
DOI: 10.1007/BF00410537.
The development of cerebral CT changes during treatment of acute lymphocytic leukemia in childhood.
Pedersen H, Clausen N
Neuroradiology. 1981; 22(2):79-84.
PMID: 6946301
DOI: 10.1007/BF00344778.
Necrotizing myelopathy associated with acute lymphoblastic leukemia. Case report and review of literature.
Grisold W, Lutz D, Wolf D
Acta Neuropathol. 1980; 49(3):231-5.
PMID: 6929156
DOI: 10.1007/BF00707111.
Necrotising leukoencephalopathy complicating treatment of childhood leukaemia.
Robain O, Dulac O, Dommergues J, Bernaudin F, Diebler K, Kalifa C
J Neurol Neurosurg Psychiatry. 1984; 47(1):65-72.
PMID: 6693915
PMC: 1027643.
DOI: 10.1136/jnnp.47.1.65.
Slight impairment of psychomotor skills in children after treatment of acute lymphoblastic leukemia.
Harten G, Stephani U, Henze G, Langermann H, Riehm H, Hanefeld F
Eur J Pediatr. 1984; 142(3):189-97.
PMID: 6590306
DOI: 10.1007/BF00442447.
Cerebrospinal fluid enolase isoenzymes and neurotoxicity in early treatment of lymphoblastic leukaemia.
Royds J, Lilleyman J, Timperley W, Taylor C
Arch Dis Child. 1984; 59(3):266-9.
PMID: 6585185
PMC: 1628534.
DOI: 10.1136/adc.59.3.266.
Letter: Treatment of C.N.S. involvement in systemic lupus erythematosis.
Lewis P, Spiers A, Pallis C
Br Med J. 1974; 4(5935):42.
PMID: 4425823
PMC: 1612105.
DOI: 10.1136/bmj.4.5935.42.
Subacute combined degeneration of the cord due to folate deficiency: response to methyl folate treatment.
Lever E, Elwes R, Williams A, Reynolds E
J Neurol Neurosurg Psychiatry. 1986; 49(10):1203-7.
PMID: 3783183
PMC: 1029058.
DOI: 10.1136/jnnp.49.10.1203.
